Page last updated: 2024-12-05

n-pentanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-pentanol: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pentan-1-ol : A short-chain primary fatty alcohol that is pentane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It has been isolated from Melicope ptelefolia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Melicopegenus[no description available]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]

Cross-References

ID SourceID
PubMed CID6276
CHEMBL ID14568
CHEBI ID44884
MeSH IDM0083864

Synonyms (107)

Synonym
AKOS009031407
alcool amylique
nsc5707
wln: q5
amyl alcohol
n-amyl alcohol
n-pentyl alcohol
n-pentanol
pentyl alcohol
amylol
pentanol ,
71-41-0
n-amylalkohol
n-pentan-1-ol
amyl alcohol, n-
nsc-5707
n-butylcarbinol
1-pentanol
pentanol-1
1-pentyl alcohol
pentasol
pentan-1-ol
PE9 ,
bdbm22603
inchi=1/c5h12o/c1-2-3-4-5-6/h6h,2-5h2,1h
un1105
butyl carbinol
NCGC00091726-01
amyl alcohol, normal
fema no. 2056
fema number 2056
n-amylalkohol [czech]
einecs 200-752-1
hsdb 111
pentanols [un1105] [flammable liquid]
petan-1-ol
butylcarbinol
alcool amylique [french]
primary amyl alcohol
ai3-01293
pentanol (van)
brn 1730975
amyl alcohol (natural)
nsc 5707
amyl alcohol, >=99%, fg
1-pentanol, acs reagent, >=99%
n-c5h11oh
CHEBI:44884 ,
amylalkohol
1-pentol
pentylalkohol
pentanols
n-pentyl-alcohol
pentyl-alcohol
1-pentanol, puriss. p.a., acs reagent, >=99.0% (gc)
MLS002415674
smr001370872
pentalcohol
CHEMBL14568
valeric alcohol
P0055
LMFA05000112
NCGC00091726-02
HMS3039G16
tox21_201107
dtxsid6021741 ,
dtxcid101741
NCGC00258659-01
cas-71-41-0
STL282712
30899-19-5
m9l931x26y ,
unii-m9l931x26y
4-01-00-01640 (beilstein handbook reference)
ec 200-752-1
FT-0608201
1-amyl alcohol
n-butyl carbinol
1-amyl alcohol [fcc]
1-pentanol [usp-rs]
amyl alcohol [fhfi]
1-pentanol [mi]
n-pentyl alcohol [hsdb]
n-pentylalcohol
pentylalcohol
l-pentanol
amyl-alcohol
amylalcohol
primary-n-amyl alcohol
mfcd00002977
amyl alcohol,primary
F0001-1831
1-pentanol, analytical standard
1-pentanol, united states pharmacopeia (usp) reference standard
1-pentanol, saj special grade, >=99.0%
1-pentanol, saj first grade, >=97.0%
1-pentanol, reagentplus(r), >=99%
1-pentanol, pharmaceutical secondary standard; certified reference material
1-pentanol, p.a., 98.0%
pentan-1-ol; 1-pentanol; pentanol; n-pentanol
amyl alcohol, primary
n-amylalkohol (czech)
c5 alcohol
amyl alcohol normal
alcool amylique (french)
Q151733
EN300-19332

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The cream produced slight erythema in rats, guinea pigs and rabbits, but the irritation indices remained within safe limits."( Safety evaluation of a barrier cream.
Gupta, BN; Mathur, AK; Shanker, R; Shukla, L; Singh, A; Viswanathan, PN, 1987
)
0.27
" The study was performed as part of a USEPA Toxic Substances Control Act (TSCA) Section 4e Enforceable Consent Agreement for amyl acetate."( Subchronic inhalation neurotoxicity study of amyl acetate in rats.
Beyrouty, PC; Gill, MW; Tyler, TR,
)
0.13
" This protection was associated with decreased formation of the toxic metabolite of APAP."( Effect of caffeine on acetaminophen hepatotoxicity in cultured hepatocytes treated with ethanol and isopentanol.
Bement, J; Chatfield, K; DiPetrillo, K; Jeffery, E; Kostrubsky, V; Sinclair, J; Sinclair, P; Wood, S; Wrighton, S, 2002
)
0.31
" We estimated oral-dose LD50 by the Up-and-Down method."( Diacetone alcohol, a dispersant solvent, contributes to acute toxicity of a fipronil-based insecticide in a passerine bird.
Astheimer, LB; Buttemer, WA; Kitulagodage, M, 2008
)
0.35
" The most toxic of the group was 2-nitro-1-propanol."( Short chain aliphatic beta-nitro alcohols for corneoscleral cross-linking: corneal endothelial toxicity studies.
Braunstein, RE; Paik, DC; Trokel, SL; Wen, Q, 2008
)
0.35
" The environmental endpoints were evaluated; for the hazard assessment based on the screening data, 1-(2-methylprop-2-enoloxy)-2,2,4-trimethylpentan-3-ol is not persistent, bioaccumulative, and toxic (PBT) as per the International Fragrance Association (IFRA) Environmental Standards."( RIFM fragrance ingredient safety assessment, 1-(2-methylprop-2-enoloxy)-2,2,4-trimethylpentan-3-ol, CAS Registry Number 526218-21-3.
Api, AM; Belsito, D; Biserta, S; Botelho, D; Bruze, M; Burton, GA; Buschmann, J; Cancellieri, MA; Dagli, ML; Date, M; Dekant, W; Deodhar, C; Fryer, AD; Gadhia, S; Jones, L; Joshi, K; Lapczynski, A; Lavelle, M; Liebler, DC; Na, M; O'Brien, D; Patel, A; Penning, TM; Ritacco, G; Rodriguez-Ropero, F; Romine, J; Sadekar, N; Salvito, D; Schultz, TW; Siddiqi, F; Sipes, IG; Sullivan, G; Thakkar, Y; Tokura, Y; Tsang, S, 2020
)
0.56
"Blends of biodiesel and high-carbon alcohols have the potential to increase the rate of biofuel use in diesel engines, while reducing harmful and toxic compounds such as polycyclic aromatic hydrocarbons (PAHs)."( Fuel effects on PAH formation, toxicity and regulated pollutants: Detailed comparison of biodiesel blends with propanol, butanol and pentanol.
Donaldson, B; Vigil, FM; Yilmaz, N, 2022
)
0.72

Pharmacokinetics

ExcerptReferenceRelevance
" The favorable pharmacokinetic profile of mapracorat supports further clinical investigation and suggests that a convenient daily dosing regimen may be efficacious for this novel ophthalmic anti-inflammatory therapy."( Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys.
Lowe, ER; Proksch, JW; Ward, KW, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
"8 × 10(-4) cm s(-1) with all mathematical approaches, indicating high absorption potential and almost complete bioavailability for all tested compounds with hydroxyl-functionalities."( Transport of hop aroma compounds across Caco-2 monolayers.
Buettner, A; Heinlein, A; Metzger, M; Walles, H, 2014
)
0.4
" To improve lipophilicity and therefore the bioavailability of menthol, a novel prodrug called menthol-pentanol was developed by masking the functional polar group of menthol by linking n-pentanol by a carbonate bond."( Anti-echinococcal activity of menthol and a novel prodrug, menthol-pentanol, against Echinococcus multilocularis.
Clemente, CM; Elissondo, MC; Elissondo, N; Fabbri, J; Gambino, G; Hergert, LY; Palma, SD; Ravetti, S, 2020
)
0.75

Dosage Studied

ExcerptRelevanceReference
" Moreover, the minimally effective dosage needed to potentiate CHCl3-induced hepatotoxicity was approximately 5 mmol/kg for the three compounds."( Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites.
du Souich, P; Greselin, E; Kobusch, AB; Plaa, GL; Vézina, M, 1990
)
0.28
"A titrimetric method is described for the determination of three acetylenic hypnotics, namely ethchlorvynol, ethinamate, and methylpentynol carbamate, in bulk and in dosage forms."( Titrimetric determination of acetylenic hyponotics using organic brominating agents.
Belal, F; el-Brashy, A; Rizk, M; Walash, MI, 1988
)
0.27
"Titrimetric and spectrophotometric titration methods are described for the quantitative determination of acetylenic hypnotics ethchlorvynol, ethinamate, and meparfynol carbamate as pure substances and in dosage forms."( Titrimetric and spectrophotometric determination of acetylenic hypnotics, using brominating agents.
el-Brashy, A; Rizk, MS; Walash, MI,
)
0.13
" Dose-response of the beetle was first examined in a trapping experiment in August 1999."( Dose-dependent response and preliminary observations on attraction range of Ips typographus to pheromones at low release rates.
Franklin, AJ; Grégoir, JC, 2001
)
0.31
" This information is critical for optimizing intravitreal dosing which in turn can aid in the design of drug delivery systems."( Disposition of short-chain aliphatic alcohols in rabbit vitreous by ocular microdialysis.
Atluri, H; Mitra, AK, 2003
)
0.32
" Ursolic, oleanolic and betulinic acids dosed at 12."( Effects of hydroxy pentacyclic triterpene acids from Forsythia viridissima on asthmatic responses to ovalbumin challenge in conscious guinea pigs.
Kim, CJ; Lee, JY; Moon, H, 2010
)
0.36
" The purpose of this investigation was to evaluate the ocular pharmacokinetics of mapracorat after topical dosing over a range of dose levels in rabbits and monkeys."( Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys.
Lowe, ER; Proksch, JW; Ward, KW, 2011
)
0.37
" This study supports the fact that GBP microemulsion obviously can not only reduce the dosage of some classes of antibiotics, but also reduce the frequency of the antibiotic use in vitro."( Polyprenols of Ginkgo biloba Enhance Antibacterial Activity of Five Classes of Antibiotics.
Chen, H; Tao, R; Wang, C; Ye, J; Zhou, H, 2016
)
0.43
" The development of effective MN delivery formulations for hydrophobic drugs is more challenging with dosing restrictions and the use of organic solvents impacting on both the bioactivity and the kinetics of drug release."( Formulation of hydrophobic peptides for skin delivery via coated microneedles.
Birchall, JC; Coulman, SA; Dayan, CM; Hanna, SJ; Wong, FS; Zhao, X, 2017
)
0.46
"6 mg N/L and Torulaspora delbrueckii Biodiva was used to ferment soy whey supplemented with either isoleucine only or isoleucine paired with valine, leucine or phenylalanine (each amino acid supplemented at a dosage of 30 mg N/L)."( Understanding the interaction of isoleucine paired with other amino acids in soy whey alcohol fermentation using Torulaspora delbrueckii.
Chua, JY; Liu, SQ; Tan, SJ, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pentanolA fatty alcohol consisting of a hydroxy function at any position of an unbranched saturated chain of five carbon atoms.
short-chain primary fatty alcohol
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency0.01580.000221.22318,912.5098AID588516
retinoid X nuclear receptor alphaHomo sapiens (human)Potency13.09260.000817.505159.3239AID1159527; AID1159531
estrogen nuclear receptor alphaHomo sapiens (human)Potency68.45010.000229.305416,493.5996AID743080
survival motor neuron protein isoform dHomo sapiens (human)Potency5.01190.125912.234435.4813AID1458
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1102450Fungitoxicity against Colletotrichum gloeosporioides assessed as mycelial growth inhibition by poisoned food technique2003Journal of agricultural and food chemistry, Aug-27, Volume: 51, Issue:18
Quantitative structure-fungitoxicity relationships of some monohydric alcohols.
AID1582364Lipophilicity, logP of the compound by 19F NMR-based method2020Journal of medicinal chemistry, 02-13, Volume: 63, Issue:3
Systematic Investigation of Lipophilicity Modulation by Aliphatic Fluorination Motifs.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID168703Inhibition of Rana pipiens muscle activity.1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,287)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990323 (25.10)18.7374
1990's158 (12.28)18.2507
2000's338 (26.26)29.6817
2010's384 (29.84)24.3611
2020's84 (6.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 71.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index71.23 (24.57)
Research Supply Index7.22 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index124.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (71.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials17 (1.27%)5.53%
Reviews47 (3.50%)6.00%
Case Studies26 (1.94%)4.05%
Observational0 (0.00%)0.25%
Other1,253 (93.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]